Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,500 | 3 | 40.8% |
| Honoraria | $4,300 | 3 | 39.0% |
| Food and Beverage | $1,979 | 132 | 17.9% |
| Education | $198.24 | 3 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51.75 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $5,955 | 17 | $0 (2024) |
| Lundbeck LLC | $2,399 | 8 | $0 (2019) |
| US WorldMeds, LLC | $1,083 | 9 | $0 (2017) |
| Allergan, Inc. | $287.53 | 27 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $275.71 | 24 | $0 (2019) |
| ABBVIE INC. | $148.11 | 8 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $137.29 | 10 | $0 (2019) |
| Merz Pharmaceuticals, LLC | $124.88 | 1 | $0 (2024) |
| Medtronic USA, Inc. | $112.03 | 6 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $111.53 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $173.20 | 4 | Merz Pharmaceuticals, LLC ($124.88) |
| 2022 | $17.97 | 1 | ABBVIE INC. ($17.97) |
| 2021 | $14.33 | 1 | AbbVie Inc. ($14.33) |
| 2020 | $14.45 | 1 | Allergan, Inc. ($14.45) |
| 2019 | $550.74 | 41 | Allergan Inc. ($124.63) |
| 2018 | $490.51 | 43 | Neurocrine Biosciences, Inc. ($111.53) |
| 2017 | $9,768 | 54 | Teva Pharmaceuticals USA, Inc. ($5,900) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: Musculoskeletal | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Central Nervous System | ||||||
| 05/12/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: VIROLOGY | ||||||
| 11/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/16/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.81 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/10/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: CNS | ||||||
| 12/02/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.47 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/25/2019 | Celgene Corporation | Ozanimod (Drug) | Food and Beverage | In-kind items and services | $96.99 | General |
| 11/18/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/14/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/11/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/27/2019 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Central Nervous System | ||||||
| 10/22/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/21/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11.15 | General |
| Category: PARKINSONS DISEASE | ||||||
| 10/08/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CNS | ||||||
| 10/08/2019 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Neuroscience | ||||||
| 09/12/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: CNS | ||||||
| 08/13/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/06/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/09/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Neuroscience | ||||||
| 06/25/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13.78 | General |
| Category: PARKINSONS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 292 | 25,915 | $487,840 | $160,697 |
| 2022 | 8 | 337 | 22,559 | $474,462 | $151,666 |
| 2021 | 8 | 400 | 21,246 | $477,881 | $153,840 |
| 2020 | 10 | 384 | 25,588 | $475,796 | $169,523 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 30 | 25,532 | $306,384 | $121,193 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 228 | $91,200 | $21,679 | 23.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 17 | 50 | $20,350 | $5,726 | 28.1% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 12 | 33 | $34,551 | $3,525 | 10.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $13,902 | $3,402 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $6,300 | $2,018 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $8,993 | $1,661 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $6,160 | $1,493 | 24.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 30 | 22,110 | $265,320 | $104,598 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 272 | $112,544 | $26,808 | 23.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 19 | 52 | $21,164 | $6,323 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $16,818 | $3,905 | 23.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $13,836 | $3,764 | 27.2% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 12 | 30 | $31,410 | $2,967 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 28 | $8,624 | $1,874 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $4,746 | $1,427 | 30.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 36 | 20,740 | $248,880 | $98,870 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 274 | $116,453 | $28,205 | 24.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $21,180 | $6,134 | 29.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 20 | 47 | $18,817 | $5,727 | 30.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 29 | 29 | $16,489 | $5,217 | 31.6% |
| 64612 | Injection of chemical for destruction of nerve muscles on one side of face | Office | 2021 | 15 | 33 | $34,551 | $3,646 | 10.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 55 | $13,332 | $3,425 | 25.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 21 | $8,179 | $2,616 | 32.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 35 | 25,075 | $300,900 | $120,476 | 40.0% |
About Dr. Amy Colcher, MD
Dr. Amy Colcher, MD is a Neurology healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174554901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Colcher, MD has received a total of $11,029 in payments from pharmaceutical and medical device companies, with $173.20 received in 2024. These payments were reported across 145 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($4,500).
As a Medicare-enrolled provider, Colcher has provided services to 1,413 Medicare beneficiaries, totaling 95,308 services with total Medicare billing of $635,727. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurological Surgery
- Location Camden, NJ
- Active Since 07/06/2006
- Last Updated 05/28/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1174554901
Products in Payments
- AUSTEDO (Drug) $5,630
- NORTHERA (Drug) $2,399
- MYOBLOC (Biological) $1,007
- APTIOM (Drug) $275.71
- BOTOX (Biological) $139.08
- NUPLAZID (Drug) $137.29
- Xeomin (Biological) $124.88
- INGREZZA (Drug) $111.53
- Ozanimod (Drug) $96.99
- ACTIVA (Device) $92.86
- BOTOX THERAPEUTIC (Biological) $89.05
- Zinbryta (Biological) $68.82
- NAMZARIC (Drug) $59.40
- APOKYN (Drug) $54.21
- SD809-HD (Drug) $53.23
- INBRIJA (Drug) $51.75
- Briviact (Drug) $33.06
- TYSABRI (Biological) $31.37
- COPAXONE (Drug) $30.25
- Aimovig (Biological) $28.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Camden
Donald Barone, Do, DO
Neurology — Payments: $476,919
Dr. Olga Thon, M.d, M.D
Neurology — Payments: $330,128
Dr. Evren Burakgazi-Dalkilic, M.d, M.D
Neurology — Payments: $113,843
Dr. Cristian Constantinescu, Md, Phd, MD, PHD
Neurology — Payments: $6,015
Dr. Jesse Thon, M.d, M.D
Neurology — Payments: $3,729
Dr. Swarna Rajagopalan, M.d, M.D
Neurology — Payments: $2,260